Cathy D. Mahle - Concepedia

Author

Cathy D. Mahle

Bristol-Myers Squibb (United States)

Also Known As

Cathy D Mahle, Cathy D. Mahle

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bayer (United States)

About

Cathy D. Mahle is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	732
2	Social Sciences	3	3	87
3	Natural Sciences	2	2	84
4	Biochemistry	2	2	46
5	Health Sciences	1	1	32

Cathy D. Mahle

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells Eric M. Parker, Darcy G. Izzarelli, Henry P. Nowak, Molecular Brain Research Molecular PharmacologySignal TransductionMolecular PhysiologyG Protein-coupled ReceptorMedicine	1995	223
Cloning of a melatonin‐related receptor from human pituitary Steven M. Reppert, David R. Weaver, Takashi Ebisawa, FEBS Letters	1996	165
Synthesis and structure–activity relationship of novel benzoxazole derivatives as melatonin receptor agonists Li‐Qiang Sun, Jie Chen, Marc A. Bruce, Bioorganic & Medicinal Chemistry Letters Structure–activity RelationshipMolecular PharmacologyMelatonin Receptor AgonistsMedicinePharmacological Agent	2004	88
Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor Zahra Fathi, Peter M Battaglino, Lawrence G. Iben, Molecular Brain Research Molecular PharmacologyMolecular CharacterizationG Protein-coupled ReceptorMedicinePharmacological Properties	1998	83
Cloning and characterization of the rat 5‐HT<sub>5B</sub>receptor William Wisden, Eric M. Parker, Cathy D. Mahle, FEBS Letters 5-Ht5b Gene ExpressionSignal TransductionDevelopmental BiologyCell SignalingPhysiology	1993	76
A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents Astrid Ortiz, Lucinda F. Milardo, Lynn B. DeCarr, Journal of Pharmacology and Experimental Therapeutics	2007	67
Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands Li‐Qiang Sun, Jie Chen, Katherine S. Takaki, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryDerivativesNatural SciencesOrganic Chemistry	2004	62
[3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain Cathy D. Mahle, Henry P. Nowak, Ronald J. Mattson, European Journal of Pharmacology Molecular NeuroscienceNeuroanatomyMedicineNeuropharmacologyNeuroscience	1991	46
Novel Selective Neuropeptide Y2 Receptor PEGylated Peptide Agonists Reduce Food Intake and Body Weight in Mice Kevin J. Lumb, Lynn B. DeCarr, Lucinda F. Milardo, Journal of Medicinal Chemistry NutritionFood IntakeGastrointestinal Peptide HormoneObesityMetabolic Syndrome	2007	32
Reduced bicuculline response and GABAA agonist binding in aged rat hippocampus Debra J. Post-Munson, J T Lum-Ragan, Cathy D. Mahle, Neurobiology of Aging Aged Rat HippocampusNeurophysiologyMedicineFunctional SelectivityPhysiology	1994	31

Page 1